by Denise Purdie Andrews | Aug 18, 2022 | Announcements
Dear Valued Client, In the spirit of continual improvement and to provide our clients with industry leading service, we are excited to announce an upcoming change in testing associated with our 42130: Synthetic Cannabinoids Panel. While these types of compounds have...
by Denise Purdie Andrews | Aug 18, 2022 | Announcements
Dear Valued Client, In the spirit of continual improvement and to provide our clients with industry leading service, we are excited to announce an upcoming change in testing associated with our 32400: Electrolyte Panel. For years this testing has been a referred test...
by Denise Purdie Andrews | Aug 8, 2022 | General
By Kevin Shanks, M.S., D-ABFT-FT We talk about false positives in forensic toxicology a lot. Could a specific drug cause a false positive for another drug on a toxicology test? The answer is a bit complex, but it is both yes and no. First, we need to talk about the...
by Denise Purdie Andrews | Jul 14, 2022 | General
By Kevin Shanks, D-ABFT-FT In toxicology testing, qualitative and quantitative testing are the norm, but every so often something prevents a result from being acquired. This “something” is called interference and will be displayed on the Axis Forensic Toxicology...
by Denise Purdie Andrews | Jun 9, 2022 | Drug Classes
By Kevin Shanks, D-ABFT-FT Over the last several years, the Drug Enforcement Administration (DEA) has moved to ban various newly emerged illicit opioids as Schedule I controlled substances. From 2015-2017, they controlled 19 fentanyl analogs and other opioids. In...
